Skip to main content


Shire PLC (SHPGY): Today's Featured Drugs Loser

Shire was a leading decliner within the drugs industry, falling $1.16 (-1.3%) to $86.32 on light volume.

Shire PLC (SHPGY): Today's Featured Health Care Winner

Shire was a winner within the health care sector, rising $2.13 (2.2%) to $98.32 on light volume.

Shire's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Shire's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Shire Stock To Go Ex-dividend Tomorrow (SHPGY)

The ex-dividend date for Shire (Nasdaq:SHPGY) is tomorrow, March 7, 2012. Owners of shares as of market close today will be eligible for a dividend of 38 cents per share. At a price of $103.18 as of 9:30 a.m., the dividend yield is 0.4%.

Five Reasons Chelsea Therapeutics' Northera Will Get FDA Approval

Last week's positive panel sets up Chelsea nicely for an FDA approval in late March.

Breaking News

Robinhood Stock Surges, Then Halted, Amid Reports of FTX Takeover Interest

Sam Bankman-Fried's FTX is looking for a path to buy online brokerage group Robinhood, Bloomberg reported Monday.

General Electric Stock Gains As CEO Larry Culp Takes Over Aviation Division

"There is tremendous opportunity in aviation over the coming years, and the Board and I decided it is the right time for me to take on this expanded role," said GE CEO Larry Culp.

Feds Could Stop Trump SPAC Deal

An investigation by a federal grand jury could halt the proposed SPAC deal with Trump's social media company.

McDonald's Brings Back a Classic Menu Item (with a Catch)

You never know what the fast-food chain might bring back or create a new version of.